Shigella flexneri evades LPS ubiquitylation through IpaH1.4-mediated degradation of RNF213
Pathogens have evolved diverse strategies to counteract host immunity. Ubiquitylation of lipopolysaccharide (LPS) on cytosol-invading bacteria by the E3 ligase RNF213 creates 'eat me' signals for antibacterial autophagy, but whether and how cytosol-adapted bacteria avoid LPS ubiquitylation remains poorly understood. Here, we show that the enterobacterium Shigella flexneri actively antagonizes LPS ubiquitylation through IpaH1.4, a secreted effector protein with ubiquitin E3 ligase activity. IpaH1.4 binds to RNF213, ubiquitylates it and targets it for proteasomal degradation, thus counteracting host-protective LPS ubiquitylation. To understand how IpaH1.4 recognizes RNF213, we determined the cryogenic electron microscopy structure of the IpaH1.4-RNF213 complex. The specificity of the interaction is achieved through the leucine-rich repeat of IpaH1.4, which binds the RING domain of RNF213 by hijacking the conserved RING interface required for binding to ubiquitin-charged E2 enzymes. IpaH1.4 also targets other E3 ligases involved in inflammation and immunity through binding to the E2-interacting face of their RING domains, including the E3 ligase LUBAC that is required for the synthesis of M1-linked ubiquitin chains on cytosol-invading bacteria downstream of RNF213. We conclude that IpaH1.4 has evolved to antagonize multiple antibacterial and proinflammatory host E3 ligases.
Authors
- Felix Randow (ORCID: https://orcid.org/0000-0003-0694-5315)
- Keith B. Boyle (ORCID: https://orcid.org/0000-0002-0745-3964)
- Ana Crespillo-Casado (ORCID: https://orcid.org/0000-0002-7230-3188)
- Elsje G. Otten (ORCID: https://orcid.org/0000-0002-8716-3560)
- Felix Scharte (ORCID: https://orcid.org/0000-0002-6710-9524)
- Pierre‐Mehdi Hammoudi (ORCID: https://orcid.org/0000-0002-8511-356X)
- Prathyush Pothukuchi (ORCID: https://orcid.org/0000-0002-6242-2319)
- Claudio Pathe (ORCID: https://orcid.org/0000-0002-2908-8988)
- Neal M. Alto (ORCID: https://orcid.org/0000-0002-7602-3853)
- Katerina Naydenova
Institutions
- MRC Laboratory of Molecular Biology (GB)
- Southwestern Medical Center (US)
- Origin Sciences (United Kingdom) (GB)
- AstraZeneca (Singapore) (SG)
- Addenbrooke's Hospital (GB)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Nature Structural & Molecular Biology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1038/s41594-025-01530-8
- Citations
- 8
- Primary Topic
- Autophagy in Disease and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 9.48
Funders
- National Science Foundation
- Wellcome Trust
- Deutsche Forschungsgemeinschaft
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- Directorate for Biological Sciences
- Medical Research Council